🩸

Understanding GP2B3A Inhibitors in Medicine

Oct 18, 2024

GP2B3A Inhibitors: A Study Guide

Introduction to GP2B3A Inhibitors

  • Class of blood thinners.
  • Includes medications: abciximab, tyrophaban, and eptafibetide.

Mnemonic for GP2B3A

  • Grand Prix on lap 2 out of 3 helps remember GP2B3A.
    • GP from Grand Prix.
    • 2B3A from lap 2 out of 3.

Mechanism of Action

  • GP2B3A (Glycoprotein 2B3A) is on platelet surface.
  • Inhibitors block this molecule to prevent platelet plug formation and blood clotting.

Drugs Overview

  • Abciximab
    • Mnemonic: ABC blocks.
    • Most common GP2B3A inhibitor.
  • Tyrophaban
    • Mnemonic: Tyrophaban Tyrannosaurus.
  • Eptafibetide
    • Mnemonic: Epitaph.

Clinical Uses

  • Anti-platelet drugs symbolized by "falling plates".
  • Prevent platelet clumping, crucial for:
    • Coronary artery stenting.
    • Coronary emergencies like unstable angina and myocardial infarctions.

Side Effects

  • Main side effect: Bleeding.
  • Symptoms include:
    • Hypotension and tachycardia.
    • Tarry stools or blood in urine.
  • Recommendation:
    • Avoid unnecessary invasive procedures.
    • Monitor hemoglobin and red blood cell levels closely.

Recap

  • GP2B3A inhibitors (abciximab, tyrophaban, eptifibatide) prevent platelet aggregation.
  • Useful in coronary procedures and emergencies.
  • Monitor for bleeding risks.

Conclusion

  • For more resources, subscribe to the channel and check out additional lessons and review materials.